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Abstract
Objectives
To assess discrepancies in the analyzed outcomes between protocols and published
reviews within Cochrane oral health systematic reviews (COHG) on the Cochrane Data-
base of Systematic Reviews (CDSR).
Study Design and Setting
All COHG systematic reviews on the CDSR and the corresponding protocols were retrieved
in November 2014 and information on the reported outcomes was recorded. Data was col-
lected at the systematic review level by two reviewers independently.
Results
One hundred and fifty two reviews were included. In relation to primary outcomes, 11.2%
were downgraded to secondary outcomes, 9.9% were omitted altogether in the final publi-
cation and new primary outcomes were identified in 18.4% of publications. For secondary
outcomes, 2% were upgraded to primary, 12.5% were omitted and 30.9% were newly intro-
duced in the publication. Overall, 45.4% of reviews had at least one discrepancy when com-
pared to the protocol; these were reported in 14.5% reviews. The number of review updates
appears to be associated with discrepancies between final review and protocol (OR: 3.18,
95% CI: 1.77, 5.74, p<0.001). The risk of reporting significant results was lower for both
downgraded outcomes [RR: 0.52, 95% CI: 0.17, 1.58, p = 0.24] and upgraded or newly
introduced outcomes [RR: 0.77, 95% CI: 0.36, 1.64, p = 0.50] compared to outcomes with
no discrepancies. The risk of reporting significant results was higher for upgraded or newly
introduced outcomes compared to downgraded outcomes (RR = 1.19, 95% CI: 0.65, 2.16,
p = 0.57). None of the comparisons reached statistical significance.
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Conclusion
While no evidence of selective outcome reporting was found in this study, based on the
present analysis of SRs published within COHG systematic reviews, discrepancies
between outcomes in pre-published protocols and final reviews continue to be common.
Solutions such as the use of standardized outcomes to reduce the prevalence of this issue
may need to be explored.
Introduction
Systematic reviews (SRs) for interventions provide the basis for evaluating the body of evidence
and by extension are uniquely influential in leading to healthcare recommendations [1,2].
However, inappropriate practices such as selective inclusion of trials, selective reporting of out-
comes and results-driven reporting can bias estimates of treatment effects culminating in com-
promised patient care, healthcare decisions and service configuration [3,4]. Selective outcome
reporting involving preferential reporting of specific data or outcomes within a study is a rec-
ognized problem and has been investigated in respect of randomized controlled trials (RCTs),
in particular [5–9].
While research on selective reporting has focused both on RCT s and non-randomized stud-
ies [10,11], similar issues may arise within SRs [12]. At the systematic review level, selective
reporting may develop for a variety of reasons, for example, due to the use of multiple measure-
ment scales, outcomes or time points [13,14] and selective inclusion of specific outcomes.
Arbitrary inclusion of outcomes based on post hoc results-driven decisions may bias the con-
clusions from subsequent syntheses [13,15].
A recent systematic review [15] has highlighted among other issues the paucity of informa-
tion on selective reporting based on comparisons between review protocols and final systematic
review reports. The limited number of meta-epidemiological analyses identified were restricted
to cystic fibrosis reviews on the Cochrane Database of Systematic Reviews (CDSR) prior to
2010 [16], or involved analysis of selected issues within the CDSR over three time periods
between 2000 and 2008 [17–19].
Historically, with the notable exception of the CDSR, systematic reviews have lacked pre-
published protocols. This has changed following the relatively recent introduction of the
PROSPERO database, and publication of SR protocols in isolation in a dedicated journal
(www.systematicreviewsjournal.com)[20], with reporting on the existence of a pre-published
protocol also encouraged within the PRISMA guidelines [2]. To our knowledge, while the exis-
tence and impact of outcome reporting bias within dental SRs has been acknowledged [21],
there are no reports addressing selective reporting and discrepancies between systematic review
protocols and final reports within the oral health field. Therefore, the aim of the present study
was to explore the prevalence and nature of selective reporting and factors associated with
selective reporting within SRs published by the Cochrane Oral Health Group (COHG) in the
CDSR by analyzing discrepancies between systematic review protocols and final reports.
Methods
All systematic reviews in the Cochrane Oral Health Group (COHG) published in the CDSR
until November, 2014 were screened for final reports and pre-published protocols. The first
author (NP) contacted the COHG in order to retrieve review protocols that were not available
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in the Cochrane library. Reviews where the protocol could not be found as well as those reviews
published in duplicate were to be excluded from further analysis.
Data were independently extracted and entered on pre-piloted standardized forms for the
eligible studies. Initial calibration was performed between the two researchers (NP, PSF) on
10 articles. Disagreements were resolved by discussion or, if necessary, with adjudication by a
third reviewer (KD). Information obtained included the number and type of primary and sec-
ondary outcomes both within the protocol and in the final publication. If a review did not dis-
tinguish between primary and secondary outcomes [unlabelled outcomes], the first three
outcomes listed were taken to be the primary outcomes and the rest considered as secondary
outcomes. Specific details as to whether outcomes present in the protocol were omitted,
upgraded or downgraded as well as inclusion of outcomes in the final report that were absent
from the protocol were recorded. Data relating to year of publication of the protocol and the
final report, and any previous versions of the review, number of authors, geographical location
of the corresponding author, whether the collaboration involved a single or multiple centers
and subject area were also extracted. In addition, information concerning statistical signifi-
cance was extracted for one primary outcome from the reviews with applicable meta-analyses.
The primary review comparison was assumed for each review[19] according to the following
hierarchy by selecting that which met the first of the following criteria: (1) an intervention
comparison described in the protocol as the primary review comparison; (2) the first interven-
tion comparison mentioned in the objectives of the protocol; (3) an intervention comparison
described in the review as the primary review comparison; (4) the first intervention compari-
son mentioned in the objectives of the review; (5) the intervention comparison used in the first
meta-analysis presented in the review.
Data Analysis
Descriptive statistics were calculated for all included articles related to the following variables:
geographical representation, number of research centers, number of review updates, number of
authors and year of publication. The year of publication was converted to a binary variable
[<2008, 2008, as from 2008 Cochrane included a requirement to declare changes between
protocol and review]. Cross-tabulations were undertaken to investigate associations between
the presence or absence of discrepancies and review characteristics. A logistic model was also
fitted in order to assess and quantify any association of discrepancies between protocol and
final review and review characteristics. Finally, upgrades, downgrades, new introductions and
omissions between protocol entries and final reports for all outcomes listed were tabulated.
Risk ratios were calculated in order to examine the relationship between possible discrepancies
in the primary outcomes and statistical significance. All statistical analyses were conducted
with Stata
1
version 13.1 software (Stata Corporation, College Station, Texas, USA).
Results
Initially 172 titles were identified in the COHG database of which 19 reviews were excluded as
duplicates [same title and DOI] and one diagnostic review was excluded (Fig 1). From the
remaining 152 reviews 116 (76.3%) had accessible protocols next to the review under the
‘‘Protocol and previous versions” section on the Cochrane Library. The COHG provided the
protocols for 36 reviews for which the protocols were not available in the Cochrane library.
A variety of conditions, interventions and outcomes were considered with the highest num-
ber of reviews dealing with dental caries, orthodontics, periodontics and implantology (S1
Table). The largest proportion of reviews originated in the UK according to the details of the
corresponding authors (S2 Table).
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The median number of labelled primary outcomes was 2 (range: 0–11) and secondary out-
comes was 4 (range: 0–36) both in the protocols and published reviews. Overall, 51 protocols
(33.6%) and 34 final reviews (22.4%) did not distinguish between primary and secondary out-
comes. This was less common among reviews published after 2008 compared to those pub-
lished prior to 2008 (OR: 0.33, 95% CI: 0.14, 0.75, p = 0.01) but no important improvement
was observed at protocol level for outcome distinction after 2008 compared to the previous
period (OR: 0.54, 95% CI: 0.25, 1.16, p = 0.11). The distribution of individual discrepancies
between protocols and reviews per geographical area, single or multicenter collaboration, num-
ber of review updates, number of authors and publication period is presented in Table 1.
According to the multivariable logistic model (Table 2) the number of review updates
appears to be associated with discrepancies between final review and protocol (OR: 3.18, 95%
CI: 1.77, 5.74, p<0.001). Geographical area, single or multicenter collaboration, review publica-
tion year and number of authors do not appear to be important predictors of discrepancies
between protocols and final reports.
The detailed analysis of discrepancies (Table 3) revealed that the primary outcome was not
stated in 3.9% (6/152) of protocols but stated in all final reports. In 30.1% (49/152) of the
reviews the primary outcomes were not consistent in the protocol and the report while second-
ary outcomes were not the same in 43.4% of the reviews (66/152). In 11.2% (17/152) of the
reviews the primary outcomes were downgraded to secondary, in 9.9% of the reviews (15/152)
they were omitted and in 18.4% (28/152) new primary outcomes were introduced. In four
reviews out of 152 (2.6%) a change in the definition was identified. In 2% (3/152) of the reviews
secondary outcomes were upgraded to primary, 12.5% (19/152) were omitted and in 30.9%
(47/152) new secondary outcomes were introduced. No outcome definition change was identi-
fied for secondary outcomes. Overall, 45.4% (69/152) of the reviews presented at least one dis-
crepancy but only in 14.5% (10/69), all published after 2008, were discrepancies reported in the
Fig 1. SR selection flow diagram.
doi:10.1371/journal.pone.0137667.g001
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text (S3 Table). It is important to point out that not all declared changes were explained in
detail or justified.
Table 1. Distribution of any discrepancies between protocols and reviews per geographical area, single or multicenter collaboration, number of
review updates, number of authors and review publication period.
Discrepancy p-value
Continent of origin of corresponding author Total no no yes yes
No. No. % No. %
Middle East & Africa 10 7 70 3 30 0.09*
Americas 15 12 80 3 20
Asia 11 7 64 4 36
Europe 116 57 49 59 51
152 79 52 73 48
Collaboration between centers
No 4 3 75 1 25 0.41*
Yes 148 80 54 68 48
Number of review updates
No updates 104 69 66 35 34 <0.001**
1 update 29 12 41 17 59
2 updates 19 2 11 17 89
Number of authors
2–3 21 11 52 10 48 0.98**
4–5 73 40 55 33 45
 6 58 32 55 26 45
Review publication period
<2008 36 24 67 12 33 0.10**
2008 116 59 51 57 49
Total 152 83 55 69 45
*Fisher’s exact test
** Chi2 test
doi:10.1371/journal.pone.0137667.t001
Table 2. Adjusted odds ratios and associated 95% confidence intervals for the association between
any discrepancies (protocol vs final report) and review characteristics.
Characteristic OR 95% CI p-value
Number of authors [per unit] 1.10 0.90, 1.34 0.34
Geographical region
Americas reference - -
Middle East & Africa 1.95 0.29, 13.34 0.50
Asia 2.15 0.35, 13.33 0.41
Europe 3.09 0.78, 12.29 0.11
Number of updates [per unit] 3.18 1.77, 5.74 <0.001
Review publication year
<2008 reference
= >2008 1.33 0.54, 3.29 0.54
Collaboration between centers
No reference - -
Yes 2.55 0.16, 41.65 0.51
doi:10.1371/journal.pone.0137667.t002
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Of the 152 reviews assessed, 89 did not have a meta-analysis or the meta-analysis did not
relate to the primary outcomes. Within the remaining reviews the distribution of discrepancies
for the primary outcome by statistical significance is shown in Table 4. The risk of reporting
significant results was lower for downgraded outcomes [RR: 0.52, 95% CI: 0.17, 1.58, p = 0.24]
and upgraded or newly introduced outcomes [RR: 0.77, 95% CI: 0.36, 1.64, p = 0.50]. The risk
of a significant result was higher for upgraded/new outcomes (RR = 1.19, 95% CI: 0.65, 2.16,
p = 0.57) compared to outcome downgrades. None of the comparisons reached statistical
significance.
Discussion
Main findings
This meta-epidemiological study attempted to identify discrepancies between 152 COHG sys-
tematic reviews and protocols in order to shed some light on selective reporting in oral health
Table 3. Tabulation of type of discrepancy between protocols and reviews for primary and secondary
outcomes at the review level.
Type of discrepancy
n %
Primary outcome variable not stated in the protocol 6/152 3.9
Primary outcome variable not stated in the published report 0/152 0.0
All primary outcome(s) stated in the protocol is/are not the same as in the published
report
47/
152
30.9
One or several primary outcome(s) stated in the protocol is downgraded to
secondary in the published report
17/
152
11.2
One or several primary outcome stated in the protocol is/are omitted from the
published report
15/
152
9.9
One or several new primary outcome(s) that was/were not stated in the protocol is
included in the published report
28/
152
18.4
The deﬁnition of one or several primary outcome(s) was different in the protocol
compared to the published report
4/152 2.6
All secondary outcomes stated in the protocol are not the same as in the published
report
66/
152
43.4
One or several non-primary outcome(s) in the protocol is/are changed to primary in
the published report
3/152 2.0
One or several secondary outcome(s) stated in the protocol is/are omitted from the
published
19/
152
12.5
One or several new secondary outcome(s) that was/were not stated in the protocol
is/are included in the published report
47/
152
30.9
The deﬁnition of one or several secondary outcome(s) was different in the protocol
compared to the published report
0/152 0.0
doi:10.1371/journal.pone.0137667.t003
Table 4. Tabulation of counts, risk ratios and associated 95% confidence intervals and p-values per type of discrepancy and statistical signifi-
cance for primary outcomes only.
Total Signiﬁcant (<0.05) Non-signiﬁcant (>0.05) Risk Ratio (95% CI) p-value
No discrepancy 24 16 8 Reference -
Downgrade 9 4 5 0.52 (0.17, 1.58) 0.24
Upgrade/Inclusion 16 9 7 0.77 (0.36, 1.64) 0.50
Total Signiﬁcant (<0.05) Non-signiﬁcant (>0.05) Risk Ratio (95% CI) p-value
Downgrade 9 4 5 Reference -
Upgrade/Inclusion 16 9 7 1.19 (0.65, 2.16) 0.57
doi:10.1371/journal.pone.0137667.t004
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systematic reviews. The reviews covered a wide range of topics and were produced by authors
located predominantly in the UK. Similar reviews have been undertaken within Cystic Fibrosis
reviews on the CDSR [16] or generally within specific issues of the CDSR covering a range of
review groups [17–19]. The most recent of the latter reviews focused on a period up to 2010
[16] identifying a discrepancy rate of up to 39%, while an earlier review alluded to a discrep-
ancy rate of 22% [17]. Our findings spanning a 16-year period indicate that within SRs in the
COHG discrepancies continue to be highly prevalent, with a prevalence of 45% for primary
outcomes. The risk for discrepancy increased with increasing number of review updates. This
is intuitive as additional outcomes can become more or less important over time with, for
example, increasing emphasis on important outcomes in recent years. Moreover, new reviewers
may differ from previous reviewers in relation to the priority with which they assign to certain
outcomes. The risk of statistically significant results was lower for both outcome downgrades
and upgrades/new inclusion compared to outcomes with no discrepancy. The finding for
upgrades/new inclusions were opposite to what was expected. The risk of statistically signifi-
cant results, consistent with other studies, was higher for outcome upgrades/new inclusions
compared to outcome downgrades. None of those finding reach statistical significance how-
ever, as data was thin.
Some of these problems with discrepancies between protocols and reviews will be addressed
when the COHG completes research being undertaken on Core Outcome Measures in Effec-
tiveness Trials (COMET; http://www.comet-initiative.org) which will provide a list of core out-
comes to be included in reviews being undertaken in certain areas of oral health.
Limitations and strengths
A large number of reviews were captured relative to published previous assessments, which
have ranged from 46 to 288 SRs [16,17]. Articles were identified by just one author in the pres-
ent study; however, as just a single database was searched with articles readily accessible, the
risk of selection bias and inappropriate omission of relevant articles is very low. We are, there-
fore, confident that the present findings are a true reflection of the discrepancy rate both for
primary and secondary outcomes with the Oral Health Group of the CDSR. The Oral Health
Group relates to reviews published within the dentistry and oral and maxillofacial surgery; pre-
vious meta-epidemiological assessments have confirmed that dental SRs are equally susceptible
to methodological and reporting weaknesses as other biomedical areas [22–25]. It is, therefore,
likely that the findings from the present review are representative of the CDSR more broadly.
Findings in context
A large number of discrepancies were identified between protocols and final reports for both
primary and secondary outcomes; these included introduction of new outcomes, upgrades,
downgrades, omissions and definition changes. Since 2008, the Cochrane Collaboration
requires that published reviews disclose discrepancies between protocols and reports. In this
study a low percentage (14.5%) of outcome discrepancies were declared. This figure is in keep-
ing with similar research with Kirkham et al. reporting acknowledgment of post hoc changes in
just 6% of 64 reviews found to have discrepancies [17]. However, in a more recent review [16]
discrepancies were mentioned in 39%, albeit based on a smaller sample of 46 reviews overall.
These figures, however, may indicate a lack of awareness among review authors and failure of
reviewers to cross-reference final submissions with pre-published protocols. While there is
ample evidence that SRs published on the CDSR are of higher methodological quality than
those published elsewhere [26–28] the stipulation of disclosure of discrepancies within the
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CDSR does not appear to have had the desired effect either within the COHG or more
generally.
In the present subset, no statistically significant association between alteration in outcomes
(upgrade from secondary to primary, introduction of new outcomes, downgrades) and statisti-
cally significant of the meta-analysis results was found. The risk for reporting significant results
was higher for upgraded or newly introduced outcomes compared to downgraded outcomes,
although a non-statistically significant finding. Kirkham et al. [19] found an increased risk of a
significant result with discrepancies including new inclusion or upgrades but not with down-
grades. The discordance in relation to upgrades/new inclusion of outcomes between these stud-
ies may be attributed to the relatively small number of included meta-analyses in the present
study but may also relate to the type of relevant outcomes.
Implications of results
The continued stubbornly high outcome discrepancy rate within the CDSR suggests that the
prerequisite of delineating changes between protocol and submitted review is ineffective. How-
ever, external screening by the Cochrane Editorial Unit from 2013 has helped to ensure these
changes are documented and justified in new reviews published since September 2013.
An alternative may be to consider a streamlined approach incorporating checks ensuring
that outcomes in the review correspond with those delineated in the protocols. This approach
could be implemented at the editorial level with proprietary software. For example, outcomes
from the protocol may be automatically transferred to the review. Where authors wish to make
changes in the review those changes would only be permitted if a declaration for changes field
was completed. The editor could then be alerted of the outcome changes between protocol and
review prompting the need for approval and registering the change. In order to improve trans-
parency consideration could be given to publication of formal protocol amendments within
the CDSR, although this would require external approval and may lead to a more protracted
publication process.
The importance of setting core outcomes common to individual trials and reviews in order
to enhance usability and transparency of reports and to reduce variability in outcome specifica-
tion [29] can also be considered as an important step in reducing discrepancies [30,31]. How-
ever, the introduction of standardised core outcome sets may, initially at least, result in more
discrepancies between reviews and protocols (particularly in review updates) as review authors
adjust their outcomes to reflect consensus core outcome sets. In time, however, it is likely that
as core outcome sets become more established it is likely that the prevalence of selective report-
ing and outcome alterations would diminish.
In terms of predictors, it appears differences between protocols and published reviews were
more likely with increasing numbers of review updates. This finding is intuitive and may reflect
the fact that reviews may span periods in excess of a decade and may, therefore, involve differ-
ent author groups. Moreover, there are instances of multiple reviews being derived from the
same protocol. The correct protocols for these “split” reviews were provided by the COHG
group office and were clearly identified. It may, however, be sensible to consider more regular
update of SR protocols within the CDSR after a defined time period to mitigate this.
In conclusion, the requirement to declare outcome changes between protocols and reviews
which was implemented in 2008 is certainly a positive, there is further evidence that discrepan-
cies still exist based on this analysis of SRs published within the Oral Health Group since its
establishment. Alternative approaches to reduce the prevalence of this issue including the use
of Core Outcome Sets need to be explored.
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